Back

Increasing co-documentation of secondary pulmonary hypertension among U.S. decedents with hypertrophic cardiomyopathy: a national mortality analysis (1999–2020)

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Diagnosis and risk stratification in hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Gaithrri Shanmuganathan

Loma Linda University Medical Centre, Loma Linda (United States of America)

6 More presentations in this session

Presentation thumbnail
Impact of the new adjusted criteria on reclassification of families with Hypertrophic Cardiomyopathy
Doctor J. Gimeno Blanes (Murcia, ES)
Abstract Slides Video
Presentation thumbnail
Sex-related differences in HCM: cardiogenetics, disease severity and major outcomes
Doctor R. Esculudes Dos Santos Ferrao Gomes (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Beyond wall thickness: clinical predictors of genotype positivity in hypertrophic cardiomyopathy
Doctor F. Juvenal (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Apical hypertrophic cardiomyopathy in transplanted hearts – a rare and heterogeneous entity
Doctor M. Deslandes (Quebec, CA)
Abstract Slides Video
Presentation thumbnail
Valsalva‑induced systolic blood pressure drop as a real‑time marker of dynamic left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Doctor Z. yu (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and risk stratification in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Evolving trends in pulmonary hypertension and mortality in heart failure
31 August 2025
thumbnail
Congress Presentation
Global and national insights into the decline of hypertrophic cardiomyopathy as a cause of sudden death in the young
2 September 2024
thumbnail
Congress Presentation
Diastolic reserve restoration drives functional improvement under mavacamten in obstructive hypertrophic cardiomyopathy: a real-world CPET–echocardiography study
29 August 2026
thumbnail
Congress Presentation
Prevalence of cardiovascular comorbidities among hospitalized patients with hypertrophic cardiomyopathy and factors associated with a higher case-fatality rate
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources